SBC Medical Group Holdings Incorporated is an innovative leader in the healthcare sector, specializing in the development of advanced medical technologies and integrated solutions aimed at improving patient care. The company concentrates on diagnostic tools and disease management systems, utilizing cutting-edge research to enhance treatment efficacy and health outcomes. With its unwavering commitment to quality and continuous innovation, SBC is well-positioned to tackle significant healthcare challenges, providing a pathway for sustainable growth and delivering long-term value for its investors and stakeholders.
| Revenue (TTM) | $169.34M |
| Gross Profit (TTM) | $119.90M |
| EBITDA | $63.73M |
| Operating Margin | 41.10% |
| Return on Equity | 16.50% |
| Return on Assets | 11.30% |
| Revenue/Share (TTM) | $1.65 |
| Book Value | $2.49 |
| Price-to-Book | — |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | -47.10% |
| Quarterly Revenue Growth (YoY) | -9.00% |
| Shares Outstanding | 0 |
| Float | $17.89M |
| % Insiders | 0.00% |
| % Institutions | 0.00% |
Volatility is currently expanding